共 50 条
- [1] Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma (vol 373, pg 2006, 2015) [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185
- [2] Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (01): : 23 - 34
- [3] Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13): : 1270 - 1270
- [4] Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21): : 2006 - 2017
- [6] Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma [J]. Experimental Hematology & Oncology, 8
- [7] Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma (vol 377, pg 1345, 2017) [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185
- [10] Nivolumab and Ipilimumab in Advanced Melanoma (vol 377, pg 2503, 2017) [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185